Universal-Beteiligungs- und Servicegesellschaft’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.66M Sell
14,263
-4,189
-23% -$2.15M 0.01% 756
2026
Q1
$9.66M Sell
18,452
-624
-3% -$298K 0.02% 614
2025
Q4
$11.1M Buy
19,076
+3,788
+25% +$1.93M 0.02% 577
2025
Q3
$7.01M Buy
15,288
+12,157
+388% +$4.54M 0.01% 729
2025
Q2
$948K Buy
3,131
+1,162
+59% +$346K ﹤0.01% 1504
2025
Q1
$652K Buy
+1,969
New +$647K ﹤0.01% 1576

Other funds holding MDGL

Universal-Beteiligungs- und Servicegesellschaft's MDGL Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Madrigal Pharmaceuticals (MDGL) stake by 23% in Q2 2026, selling an estimated $2.15M and leaving 14,263 shares worth $7.66M. The position accounts for 0.01% of the portfolio, ranked #756.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in MDGL in Q1 2025 and has held it in 6 quarters since. The position peaked at $11.1M in Q4 2025. 229 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 14,263 shares of Madrigal Pharmaceuticals worth $7.66M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 4,189 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.15M.
  • Madrigal Pharmaceuticals made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #756 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Madrigal Pharmaceuticals position peaked at $11.1M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.